Please assess the completion status of the following clinical trial:

Trial Title: Tasso-SST OnDemand Comparator Pilot Study

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Must be a study participant enrolled in the MURDOCK C3PI Study (Pro00105703), participating in the testing cohort of the study.~* Participants are therefore 18 years of age or older, and~* willing to read and complete the consent process.~Exclusion Criteria:~* No exclusion criteria; however, only up to 100 participants will be enrolled. If more than 100 participants sign consent, some interested participants may not take part in the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Tasso- SST blood collection (Type: OTHER): About 100 participants will have blood collected by two methods-regular phlebotomy and Tasso-SST, in this pilot study.
- Regular Venipuncture (Type: OTHER): About 100 participants will have blood collected by two methods-regular phlebotomy and Tasso-SST, in this pilot study.

Based on this trial design, predict the completion outcome and termination type (if applicable).